業績

 > 業績 > 学位取得者

  • 当科紹介
  • 診療内容
  • 受診について
  • 臨床試験・先進医療
  • 業績
  • 研究医・学生の皆さんへ
  • 年中行事

学位取得者

2017年度

秋山 真吾

Prognostic impact of MutT homolog-1 expression on esophageal squamous cell carcinoma
Shingo Akiyama, Hiroshi Saeki, Yuichiro Nakashima, Makoto Iimori, Hiroyuki Kitao, Eiji Oki, Yoshinao Oda, Yusaku Nakabeppu, Yoshihiro Kakeji, Yoshihiko Maehara
Cancer Medicine. 2017 Jan; 6(1): 258-266

石田 諒

The Tissue Reconstructing Ability of Colon CSCs is Enhanced by FK506 and Suppressed by GSK3 Inhibition
Ryo Ishida, Michiyo Koyanagi-Aoi, Nobu Oshima, Yoshihiro Kakeji, Takashi Aoi
Mol Cancer Res. 2017 Oct;15(10):1455-1466.

前原 律子

SOX2-silenced squamous cell carcinoma: A highly malignant form of esophageal cancer with SOX2 promoter hypermethylation.
Maehara R, Fujikura K, Takeuchi K, Akita M, Abe-Suzuki S, Karbanova J, Corbeil D, Itoh T, Kakeji Y, Zen Y.
Modern Pathology. 2018 Jan;31(1):83-92

中川 暁雄

The Surgical Apgar Score Predicts Not Only Short-Term Complications But Also Long-Term Prognosis After Esophagectomy
Akio Nakagawa, Tetsu Nakamura, Taro Oshikiri, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda Yasuo Sumi, Satoshi Suzuki, and Yoshihiro Kakeji
Ann Surg Oncol. 2017 Dec;24(13):3934-3946.

細野 雅義

CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells
Masayoshi Hosono, Yu-ichiro Koma, Nobuhisa Takase, Naoki Urakawa, Nobuhide Higashino, Kazuki Suemune, Himiko Kodaira, Mari Nishio, Manabu Shigeoka, Yoshihiro Kakeji and Hiroshi Yokozaki
Oncotarget. 2017 Dec 1; 8(62):

多田羅 敬

Expression of programmed death-1 (PD-1) in sentinel lymph nodes of breast cancer
Takashi Tatara, Toru Mukohara, Yohei Shimono, Takashi Yamazaki, Yoshinori Imamura,
Yohei Funakoshi, Masanori Toyoda, Naomi Kiyota, Seishi Kono, Shintaro Takao, Yoshihiro Kakeji, Hironobu Minami
Journal of Surgical Oncology 2017 Nov 28

原田 仁

The learning effect of using stereoscopic vision in the early phase of laparoscopic surgical training for novices
Harada H, Kanaji S, Nishi M, Otake Y, Hasegawa H, Yamamoto M, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Sumi Y, Nakamura T, Suzuki S, Sato Y, Kakeji Y
Surg Endosc. 2018 Feb;32(2):582-588.

2016年度

高瀬 信尚

NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulate the survival and migration of tumor-associated macrophages and cancer cells
Nobuhisa Takase, Yu-ichiro Koma, Naoki Urakawa, Mari Nishio, Noriaki Arai, Hiroaki Akiyama, Manabu Shigeoka, Yoshihiro Kakeji, Hiroshi Yokozaki
Cancer Letters 380 (2016) 47–58. doi.org/10.1016/j.canlet.2016.06.009

音羽 泰則

Flt1/VEGFR1 heterozygosity causes transient embryonic edema
Yasunori Otowa, Kazumasa Moriwaki, Keigo Sano, Masanori Shirakabe, Shigenobu Yonemura, Masabumi Shibuya, Janet Rossant, Toshio Suda, Yoshihiro Kakeji, Masanori Hirashima
Sci Rep. 2016 Jun 2;6:27186 . doi: 10.1038/srep27186.

西 将康

Quantitative comparison of operative skill using 2- and 3- dimensional monitors during laparoscopic phantom tasks.
Masayasu Nishi, Shingo Kanaji, Yoshito Otake, Hitoshi Harada, Masashi Yamamoto, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yuki Suzuki, Yuta Hiasa, Yoshinobu Sato, Yoshihiro Kakeji
Surgery 2017 May;161(5):1334-1340

向山 順子

Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens.
Junko Mukohyama, Dai Iwakiri, Yoh Zen, Toru Mukohara, Hironobu Minami, Yoshihiro Kakeji, Yohei Shimono
Oncotarget. 2016 Aug 2;7(31):50150-50160. doi: 10.18632/oncotarget.10322.

2015年度

大坪 大

Early-phase Treatment by Low-dose 5-Fluorouracil or Primary Tumor Resection Inhibits MDSC-mediated Lung Metastasis Formation.
Otsubo D, Yamashita K, Fujita M, Nishi M, Kimura Y, Hasegawa H, Suzuki S, Kakeji Y
Anticancer Res. 2015 Aug;35(8):4425-31.

瀧口 豪介

Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16–CXCR6 axis
Gosuke Takiguchi, Michiru Nishita, Kana Kurita, Yoshihiro Kakeji and Yasuhiro Minami
Cancer Science 2016 Mar;107(3):290-7. doi: 10.1111/cas.12871

2014年度

長谷川 寛

Allogeneic DCG Promote Lung NK Cell Activation and Antitumor Effect After Invariant NKT Cell Activation
Hiroshi Hasegawa, Kimihiro Yamashita, Dai Otubo, Shin-ichiro Fujii, Takashi Kamigaki, Daisuke Kuroda, Yoshihiro Kakeji
ANTICANCER RESEARCH. 2014; 34: 3411-3418

裏川 直樹

GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways
Naoki Urakawa, Soken Utsunomiya, Mari Nishio, Manabu Shigeoka, Nobuhisa Takase, Noriaki Arai,
Yoshihiro Kakeji, Yu-ichiro Koma, Hiroshi Yokozaki
Laboratory Investigation. 2015 Mar 2. doi: 10.1038/labinvest.2015.36.

友野 絢子

Cell cycle kinetic analysis of colorectal neoplasms using a new automated immunohistochemistry-based cell cycle detection method.
Tomono A,Itoh T,Yanagita E,Imagawa N,Kakeji Y.
Medicine(Baltimore).2015 Jan;94(4):e501.

ページトップへ戻る

神戸大学大学院医学研究科外科学講座 食道胃腸外科学分野
〒650-0017 神戸市中央区楠町7丁目5-2 TEL 078-382-5925 FAX 078-382-5939
Copyright (C) 2008-2012 Kobe University Hospital, Dept. of Surg. All Rights Reserved.